The effect of metabolic syndrome on the fertility of women of reproductive age

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Purpose. To study the effect of metabolic syndrome (MS) on the fertility of women of reproductive age using standard clinical diagnostic methods.

Material and methods. 242 women of reproductive age took part in the prospective open-open clinical and epidemiological study, of which 120 detected MS. All patients conducted a standard clinical and instrumental-laboratory examination to assess the state of health before the planned pregnancy. The results were obtained using descriptive statistics.

Results. The results indicate the influence of even MS 1st degree on a decrease in fertility in women.

Conclusion. Thus, even with MS of the 1st degree, women of reproductive age need to observe from doctors of obstetrician-gynecologists and doctors of other specialties in order to timely diagnose and prevent complications to maintain reproductive health and increase the birth rate of the population.

全文:

受限制的访问

作者简介

M. Martina

Yaroslavl State Medical University, Ministry of Health of Russia

Email: rchilova@gmail.com
ORCID iD: 0009-0006-9630-1546
俄罗斯联邦, Yaroslavl

M. Ilyin

Yaroslavl State Medical University, Ministry of Health of Russia

Email: rchilova@gmail.com
ORCID iD: 0000-0001-6278-374X
SPIN 代码: 2936-4312

Professor, MD

俄罗斯联邦, Yaroslavl

R. Chilova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

编辑信件的主要联系方式.
Email: rchilova@gmail.com
ORCID iD: 0000-0001-6331-3109
SPIN 代码: 4137-4848

Professor, MD

俄罗斯联邦

M. Savelyeva

Yaroslavl State Medical University, Ministry of Health of Russia

Email: rchilova@gmail.com
ORCID iD: 0000-0002-2373-2250
SPIN 代码: 2434-6458

Professor, MD

俄罗斯联邦, Yaroslavl

T. Valiev

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

Email: rchilova@gmail.com
ORCID iD: 0000-0002-1469-2365
SPIN 代码: 9802-8610

Professor, MD

俄罗斯联邦, Moscow; Moscow

M. Kovalev

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rchilova@gmail.com
ORCID iD: 0000-0002-0426-587X
SPIN 代码: 2539-6420

Professor, MD

俄罗斯联邦

M. Zholobova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rchilova@gmail.com
ORCID iD: 0000-0003-2842-2910

Candidate of Medical Sciences

俄罗斯联邦

M. Poznyak

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rchilova@gmail.com
ORCID iD: 0009-0006-8217-0784
俄罗斯联邦

I. Gadaeva

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rchilova@gmail.com
ORCID iD: 0000-0003-0144-4984
SPIN 代码: 9593-1990

Candidate of Medical Sciences

俄罗斯联邦

G. Sevastyanov

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rchilova@gmail.com
ORCID iD: 0009-0000-4823-9510
俄罗斯联邦

参考

  1. Marinelli S., Napoletano G., Straccamore M. et al. Female obesity and infertility: outcomes and regulatory guidance. Acta Biomed. 2022; 93 (4): e2022278. doi: 10.23750/abm.v93i4.13466
  2. Notaro A.L.G., Neto F.T.L. The use of metformin in women with polycystic ovary syndrome: an updated review. J Assist Reprod Genet. 2022; 39 (3): 573–9. doi: 10.1007/s10815-022-02429-9
  3. Мартина М.Н., Чилова Р.А., Сокова Е.А. и др. Эффективность терапии метформином и сибутрамином у пациенток с бесплодием, ассоциированным с метаболическим синдромом. Врач. 2024; 35 (5): 62–5 [Martina M., Chilova R., Sokova E. et al. Efficacy of metformin and sibutramine therapy in patients with infertility associated with metabolic syndrome. Vrach. 2024; 35 (5): 62–5 (in Russ.)]. doi: 10.29296/25877305-2024-05-11
  4. Хабибулина М.М., Шамилов М.Д. Фитоэстрогены («Фемо-Клим») и психологическое состояние при гипоэстрогении и абдоминальном ожирении. Акушерство и гинекология. Новости. Мнения. Обучение. 2022; 10 (3): 107–12 [Khabibulina M.M., Shamilov M.D. Phytoestrogens ("Femo-Klim") and psychological state in women with hypoestrogenism and abdominal obesity. Obstetrics and Gynecology: News, Opinions, Training. 2022; 10 (3): 107–12 (in Russ.)]. doi: 10.33029/2303-9698-2022-10-3-107-112
  5. Хабибулина М.М. Влияние альтернативного варианта заместительной гормональной терапии на кардиальные проявления при метаболически здоровом ожирении и гипоэстрогенемии. Фармация. 2022; 71 (4): 46–51 [Khabibulina M.M. The influence of an alternative variant of hormone replacement therapy on cardiac manifestations in metabolically healthy obesity and hypoestrogenemia. Pharmacy. 2022; 71 (4): 46–51 (in Russ.)]. doi: 10.29296/25419218-2022-04-07
  6. Клинические рекомендации Минздрава России «Рекомендации по ведению больных с метаболическим синдромом», 2013 [Clinical Recommendations of the Ministry of Health of Russia “Recommendations for the management of patients with metabolic syndrome”, 2013. (in Russ.)]. URL: https://doc-way.ru/sites/default/files/2022-09/cr_18_0.pdf
  7. Bond S.T., Calkin A.C.., Drew BG. Adipose-Derived Extracellular Vesicles: Systemic Messengers and Metabolic Regulators in Health and Disease. Front Physiol. 2022; 13: 837001. doi: 10.3389/fphys.2022.837001
  8. Волынец Л.И., Конышко Н.А., Конышко Г.С. и др. Дислипидемия беременных женщин в норме и при патологии. Возможности лекарственной терапии. Вопросы гинекологии, акушерства и перинатологии. 2023; 22(5): 87–94 [Volynets L.I., Konyshko N.A., Konyshko G.S. et al. Dyslipidemia of pregnancy in normal and complicated pregnancies. Possibilities of pharmacotherapy. Gynecology, Obstetrics and Perinatology. 2023; 22 (5): 87–94 (in Russ.)]. doi: 10.20953/1726-1678-2023-5-87-94
  9. Ibrahim R.H., Shelbaya S.A., Elhalawany S.H. et al. Study of the relation between serum omentin-1 levels and insulin resistance in gestational diabetes mellitus. Gynecology, Obstetrics and Perinatology. 2023; 22 (4): 32–8. doi: 10.20953/1726-1678-2023-4-32-38
  10. Ремнева О.В., Чернова А.Е., Колядо О.В. и др. Медико-социальные факторы риска позднего самопроизвольного выкидыша. Вопросы гинекологии, акушерства и перинатологии. 2022; 21 (6): 73–8 [Remneva O.V., Chernova A.E., Kolyado O.V. et al. Medical and social risk factors for late miscarriage. Gynecology, Obstetrics and Perinatology. 2022; 21 (6): 73–8 (in Russ.)]. doi: 10.20953/1726-1678-2022-6-73-78
  11. Zheng L., Yang L., Guo Z. et al. Obesity and its impact on female reproductive health: unraveling the connections. Front Endocrinol (Lausanne). 2024; 14: 1326546. doi: 10.3389/fendo.2023.1326546
  12. Аляутдина О.С., Прилуцкая В.Ю. Сравнение эффективности применения инозитолов и комбинированных оральных контрацептивов для коррекции метаболических, эндокринных и клинических параметров пациенток с синдромом поликистозных яичников. Вопросы гинекологии, акушерства и перинатологии. 2022; 21 (1): 43–50 [Alyautdina O.S., Prilutskaya V.Yu. Comparison of efficacy of inositol and combined oral contraceptives for correction of metabolic, endocrine, and clinical parameters in patients with polycystic ovary syndrome. Gynecology, Obstetrics and Perinatology. 2022; 21 (1): 43–50 (in Russ.)]. doi: 10.20953/1726-1678-2022-1-43-50
  13. Lee J., Choo C.W., Moon K.Y. et al. Risk Factors for Infertility in Korean Women. J Korean Med Sci. 2024; 39 (10): e85. doi: 10.3346/jkms.2024.39.e85
  14. Wise L.A., Palmer J.R., Rosenberg L. Body size and time-to-pregnancy in black women. Hum Reprod. 2013; 28 (10): 2856–64. doi: 10.1093/humrep/det333
  15. Liu C., Dou Y., Zhang M. et al. High-fat and high-sucrose diet impairs female reproduction by altering ovarian transcriptomic and metabolic signatures. J Transl Med. 2024; 22 (1): 145. doi: 10.1186/s12967-024-04952-y
  16. Stunkard A.J., Sørensen T.I., Hanis C. et al. An adoption study of human obesity. N Engl J Med. 1986; 314 (4): 193–8. doi: 10.1056/NEJM198601233140401

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. 1. Frequency of metabolic syndrome

下载 (75KB)
索引源数据
3. Fig. 2. Frequency of occurrence of infertility factors

下载 (93KB)
索引源数据
4. Fig. 3. Frequency assessment of the use of assisted reproductive technologies in the study groups

下载 (82KB)
索引源数据
5. Fig. 4. Frequency assessment of the use of in vitro fertilization methods in the study groups

下载 (80KB)
索引源数据

版权所有 © Russkiy Vrach Publishing House, 2025